TP53 and non-small cell lung carcinoma: This suggested that there was a correlation between p53 protein expression and chemosensitivity of platinum drugs in patients with advanced NSCLC, and the chemosensitivity of patients with negative expression of p53 protein was higher than that of patients with positive expression of p53 protein, especially in advanced NSCLC.